Skip to content

AJPhar: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

AJPhar

BE 0778.569.213
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€9,013
2024 · €1,433-€10,446
Equity
€2,104
2024 · €11,117-€9,013
Cash
€5,330
2024 · €24,119-€18,789
Balance sheet total
€6,429
2024 · €30,746-€24,317

Largest movements

2024 to 2025
Assets
  • Cash -€18,789

    down €18,789 (-77.9%), from €24,119 to €5,330

    mainly Net result for the year (-€9,013) and Other debts (-€7,665)

  • Receivables within one year -€4,520

    down €4,520 (-98.1%), from €4,608 to €88

    of which Trade receivables: -€4,608

  • Deferred charges and accrued income -€474

    no longer reported in 2025 (was €474)

  • Tangible fixed assets -€458

    down €458 (-31.2%), from €1,469 to €1,011

Equity and liabilities
  • Profit (loss) carried forward -€9,013

    down €9,013, from €433 to -€8,580

  • Other debts -€7,665

    down €7,665 (-65.9%), from €11,626 to €3,962

  • Tax, wage and social debts -€7,242

    no longer reported in 2025 (was €7,242)

  • Trade debts -€398

    down €398 (-52.3%), from €761 to €363

Income statement
  • Gross operating margin -€10,065

    down €10,065, from €9,618 to -€447

  • Other operating charges +€4,208

    up €4,208 (+171%), from €2,454 to €6,661

  • Taxes -€1,737

    no longer reported in 2025 (was €1,737)

  • Financial charges -€1,255

    down €1,255 (-47.0%), from €2,673 to €1,418

  • Depreciation -€844

    down €844 (-61.3%), from €1,378 to €534

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €1,433
Gross operating margin -€10,065
Depreciation +€844
Other operating charges -€4,208
Financial income -€10
Financial charges +€1,255
Taxes +€1,737
Result 2025 -€9,013
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€18,789
Investment €0
Financing €0
Cash 2024 €24,119
Net result for the year -€9,013
Depreciation +€534
Receivables within one year +€4,520
Deferred charges and accrued income +€474
Trade debts -€398
Tax, wage and social debts -€7,242
Other debts -€7,665
Cash 2025 €5,330
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €30,746 €6,429 -€24,317 -79.1%
Formation expenses 20 €76 €0 -€76 -100%
Fixed assets 21/28 €1,469 €1,011 -€458 -31.2%
Tangible fixed assets 22/27 €1,469 €1,011 -€458 -31.2%
Plant, machinery and equipment 23 €1,469 €1,011 -€458 -31.2%
Current assets 29/58 €29,201 €5,418 -€23,783 -81.4%
Amounts receivable within one year 40/41 €4,608 €88 -€4,520 -98.1%
Trade receivables 40 €4,608 - -€4,608
Other amounts receivable 41 - €88 +€88
Cash at bank and in hand 54/58 €24,119 €5,330 -€18,789 -77.9%
Deferred charges and accrued income 490/1 €474 - -€474
Total equity and liabilities 10/49 €30,746 €6,429 -€24,317 -79.1%
Equity 10/15 €11,117 €2,104 -€9,013 -81.1%
Contributions 10/11 €4,000 €4,000 = 0.0%
Reserves 13 €6,684 €6,684 = 0.0%
Distributable reserves 133 €6,684 €6,684 = 0.0%
Profit (loss) carried forward 14 €433 -€8,580 -€9,013
Amounts payable 17/49 €19,628 €4,325 -€15,304 -78.0%
Amounts payable within one year 42/48 €19,628 €4,325 -€15,304 -78.0%
Trade debts 44 €761 €363 -€398 -52.3%
Suppliers 440/4 €761 €363 -€398 -52.3%
Taxes, remuneration and social security 45 €7,242 - -€7,242
Taxes 450/3 €7,242 - -€7,242
Other amounts payable 47/48 €11,626 €3,962 -€7,665 -65.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,378 €534 -€844 -61.3%
Other operating charges 640/8 €2,454 €6,661 +€4,208 +171%
Gross operating margin 9900 €9,618 -€447 -€10,065
Operating profit (loss) 9901 €5,786 -€7,642 -€13,428
Financial income 75/76B €58 €47 -€10 -18.2%
Recurring financial income 75 €58 €47 -€10 -18.2%
Financial charges 65/66B €2,673 €1,418 -€1,255 -47.0%
Recurring financial charges 65 €2,673 €1,418 -€1,255 -47.0%
Profit (loss) for the period before taxes 9903 €3,170 -€9,013 -€12,183
Income taxes 67/77 €1,737 - -€1,737
Profit (loss) for the period 9904 €1,433 -€9,013 -€10,446
Profit (loss) for the period to be appropriated 9905 €1,433 -€9,013 -€10,446

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.